Stockreport

Infinity Pharmaceuticals Appoints Robert Ilaria, Jr., M.D., as Chief Medical Officer and Brian Schwartz, M.D., to Its Board of Directors

Infinity Pharmaceuticals, Inc.  (INFI) 
Last infinity pharmaceuticals, inc. earnings: 10/30 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.infi.com/investor-overview
PDF – Experienced leader in immuno-oncology drug development Robert Ilaria, Jr. to head eganelisib clinical development – – Brian Schwartz, M.D., transitioning from Consulti [Read more]